DEERFIELD MANAGEMENT COMPANY, L.P. Q4 2020 Filing

Filed February 16, 2021

Portfolio Value

$5.1T

Holdings

129

Report Date

Q4 2020

Filing Type

13F-HR

All Holdings (129 positions)

#StockSharesValue% PortfolioType
101
MEDTECH ACQUISITION CORP
1,000,000$10.5B0.21%
102
HIGHCAPE CAP ACQUISITION COR
1,000,000$10.3B0.20%
103
SENIOR CONNECT ACQUISITN COR
1,000,000$10.3B0.20%
104
TURNING POINT THERAPEUTICS I
83,846$10.2B0.20%
105
STIMNEURONETICS INC
919,000$10.2B0.20%
106
OMGBPOUTSET MED INC
175,000$9.9B0.20%
107
BCABBIOATLA INC
280,422$9.5B0.19%
108
DCTHDELCATH SYS INC
500,000$9.0B0.18%
109
TURMERIC ACQUISITION CORP
750,000$7.7B0.15%
110
SIENUSDSIENTRA INC
1,918,118$7.5B0.15%
111
SILKSILK RD MED INC
113,000$7.1B0.14%
112
TSHATAYSHA GENE THERAPIES INC
250,000$6.6B0.13%
113
CERE1EURCEREVEL THERAPEUTICS HLDNG I
385,043$6.4B0.13%
114
PANACEA ACQUISITION CORP
500,000$6.4B0.13%
115
ARVNARVINAS INC
75,000$6.4B0.13%
116
FDMT4D MOLECULAR THERAPEUTICS IN
150,000$6.2B0.12%
117
INTERSECT ENT INC
255,456$5.8B0.12%
118
CABACABALETTA BIO INC
464,252$5.8B0.11%
119
BNFT 1.25 12/15/23BENEFITFOCUS INC
6,500,000$5.7B0.11%
120
EARGO INC
125,000$5.6B0.11%
121
CONSONANCE HFW ACQUISITION C
500,000$5.2B0.10%
122
LONGVIEW ACQUISITION CORP
733,333$4.8B0.10%
123
MASS908 DEVICES INC
75,000$4.3B0.08%
124
METACRINE INC
277,469$2.2B0.04%
125
VCELVERICEL CORP
64,946$2.0B0.04%
126
FUSION PHARMACEUTICALS INC
162,378$1.9B0.04%
127
CEREVEL THERAPEUTICS HLDNG I
166,666$942.0M0.02%
128
NEOS THERAPEUTICS INC
320,993$201.0M0.00%
129
WINTWINDTREE THERAPEUTICS INC
20,148$103.0M0.00%
PreviousPage 2 of 2